[144] TD SYNNEX Corporation SEC Filing

Rhea-AI Filing Summary

TD SYNNEX (SNX) insider notice to sell 3,445 common shares. The Form 144 shows 3,445 shares offered through Morgan Stanley Smith Barney with an aggregate market value of $504,933.65, representing approximately 0.0042% of 82,467,079 outstanding shares. The shares were acquired and paid for on 08/11/2025 by exercise of stock options and the planned sale is listed for the same date.

The filing also records prior 10b5-1 sales by the same person of 1,509 shares on 06/18/2025 that generated $189,148.32 in gross proceeds. The notice includes the standard insider representation that no material nonpublic information is known to the seller.

Positive

• Timely disclosure: Form 144 filed to report proposed sale, meeting regulatory transparency expectations
• Broker-handled execution: Sale listed through a major broker, indicating orderly disposition
• Prior 10b5-1 sales recorded: June 18 sale of 1,509 shares suggests at least some sales were pre-planned

Negative

• Insider selling: The person for whose account the shares are sold has recently exercised options and is disposing of shares, which some investors interpret negatively
• Aggregate value: $504,933.65 sale could attract attention despite being immaterial relative to outstanding shares

Insights

Securities Analyst

TL;DR: Insider exercised options and plans a small, routine sale of 3,445 SNX shares worth $504,934; size is immaterial to capitalization.

The filing documents a contemporaneous exercise of stock options and a proposed sale of the resulting 3,445 common shares through a broker, valued at $504,933.65. Measured against the stated shares outstanding (82,467,079), the disposal equals roughly 0.0042% of the float, which would not materially affect supply-demand dynamics. A prior 10b5-1 sale of 1,509 shares produced $189,148.32, suggesting at least some structured selling activity. Overall, this appears operational (option exercise) and routine rather than a signal of material company-specific news.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements and references prior 10b5-1 activity, indicating compliant, pre-planned insider selling.

The notice includes the required representations about material nonpublic information and records a broker-handled transaction. The presence of a listed 10b5-1 sale in June implies planned disposals rather than opportunistic insider trades. From a governance perspective, timely Form 144 filing and use of a broker are positive compliance indicators. The absolute size of the sale is negligible relative to outstanding shares, so governance risk from this transaction is low.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3445	504933.65	82467079	08/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/11/2025	Exercise of Stock Options	Issuer			3445	08/11/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MARSHALL WITT 44201 Nobel Drive Fremont CA 94538	Common	06/18/2025	1509	189148.32

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the SNX Form 144 report?

The Form 144 reports a proposed sale of 3,445 common shares through a broker with an aggregate market value of $504,933.65.

How were the 3,445 SNX shares acquired?

The shares were acquired on 08/11/2025 by exercise of stock options and paid for in cash on that date.

Has the insider sold SNX shares recently?

Yes. The filing records a prior 10b5-1 sale of 1,509 shares on 06/18/2025 that produced $189,148.32 in gross proceeds.

What percentage of outstanding SNX shares is 3,445 shares?

Based on the filing's 82,467,079 shares outstanding, 3,445 shares equal approximately 0.0042% of outstanding shares.

Through which exchange will the SNX shares be sold?

The sale is listed for execution on the NYSE using Morgan Stanley Smith Barney as the broker.